UPDATE 1-Valeant Pharma says may buy back up to $2 bln worth of securities
November 20, 2014 at 13:37 PM EST
Nov 20 (Reuters) - Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion worth of securities, replacing a previous $1.5 billion program under which it bought back no securities.